Overview 505(b)(2): Is it for you?Comprehensive Service Offerings Success Stories Scientific Library Press releases/news Publications Presentations Case Studies Events

Presentations by experts at Camargo Pharmaceutical Services

Camargo experts frequently present at professional meetings of a wide variety of scientific and healthcare organizations, symposia and world congresses. Here are some details about some of their many presentations, abstracts and posters.

For an introduction to the many contributions that members of Camargo have made to professional peer literature, see Publications.

Stevens, Ph.D., Stacey A. Ayres, Ph.D., and Ken V. Phelps, B.S. Atrophic Vaginitis: Effect of Low-Dose Cenestin®. International Society for the Study of Women’s Sexual Health [ISSWSH] 2002, Oct. 10-13, Vancouver, British Columbia, Canada.
R.E. Stevens, PhD, S.A. Ayres, PhD; K.V. Phelps, B.S. Low Dose Cenestin®, Vaginal Cytology and pH: Impact of Previous ERT Exposure and BMI. North American Menopausal Society (NAMS) Annual Meeting 2002, Chicago, IL, Oct. 3-5, 2002.
Ruth E. Stevens, Ph.D., Ray Klein, M.D., Cindy Phurrough, B.S., R.Ph., Stacey A. Ayres, Ph.D., and Ken V. Phelps, B.S. Effect of Low-Dose Cenestin® in Atrophic Vaginitis. 10th Anniversary Congress on Women’s Health 2002, May 18-21, Hilton Head, South Carolina.
Stacey A. Ayres, Ph.D., Ruth E. Stevens, Ph.D., Ray Klein, M.D. and Ken V. Phelps, B.S. Effect of Cenestin® on Serum Triglycerides in Postmenopausal Women: Influence of Risk Factors. 10th Anniversary Congress on Women’s Health 2002, May 18-21, Hilton Head, South Carolina.
R.E. Stevens, S.A. Ayres, P.Roy, K.V. Phelps. Effect Of Estrogen Replacement Therapy On Climacteric Symptoms In African-American And Caucasian Women: Influence Of Cigarette Smoking. 103rd Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Atlanta, GA, March 24-27, 2002.
R.E. Stevens, P.Roy, K.V. Phelps. Bioavailability of Ethinyl Estradiol from Combination Oral Contraceptives: Reliable and Consistent Delivery from Duramed Formulations. American Association of Pharmaceutical Scientists (AAPS) 17th Annual Meeting, Denver Colorado, Oct. 21 – Oct. 26, 2001.
R.E. Stevens, P.Roy, K.V. Phelps. Bioavailability of Desogestrel and Ethinyl Estradiol (Apri® and Ortho-Cept® 21 tablet) Oral Contraceptive Products. American Association of Pharmaceutical Scientists (AAPS) 17th Annual Meeting, Denver Colorado, Oct. 21 – Oct. 26, 2001.
P. Roy, R.E. Stevens, E. Fredricks, K.V. Phelps. Application of First-order Higuchi Release Kinetics To Compare Two Slow-Release Conjugated Estrogens Formulations: Synthetic Conjugated Estrogens, A (Cenestin®) versus Conjugated Estrogens, USP (Premarin®). American association of Pharmaceutical Scientists (AAPS) 17th Annual Meeting, Denver Colorado, Oct. 21 – Oct. 26, 2001.
P. Roy, R.E. Stevens, K.V. Phelps. Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study Of Synthetic Conjugated Estrogens, A (Cenestin®): One 1.25 mg Tablet Versus Two 0.625 mg Tablets In Healthy, Post-Menopausal Women Under Fasting Conditions. American Association of Pharmaceutical Scientists (AAPS) 17th Annual Meeting, Denver Colorado, Oct. 21 – Oct. 26, 2001.
R.E. Stevens, P. Roy, K.V. Phelps. Bioavailability of Levonorgestrel and Ethinyl Estradiol (Aviane™ and Alesse™-21 tablet) Oral Contraceptive Products. American Association of Pharmaceutical Scientists (AAPS) 17th Annual Meeting, Denver Colorado, Oct. 21 – Oct. 26, 2001.
R.E. Stevens, Ph.D., S.A. Ayres, Ph.D. and K.V. Phelps, B.S. Association between Steady-State CenestinÒ (Synthetic Conjugated Estrogens, A) Plasma Estrone Concentrations And U-NTX Biochemical Marker of Bone Turnover in Postmenopausal Women. American Society for Bone and Mineral Research (ASBMR), 23nd Annual Meeting, Phoenix Arizona, Oct. 12-16, 2001.
S.A. Ayres, Ph.D., R.E. Stevens, Ph.D. and K.V. Phelps, B.S. Effect of Cenestin® (Synthetic Conjugated Estrogens, A) on Biochemical Markers of Bone Turnover in non-Hispanic Caucasian and Mexican-American Postmenopausal Women. American Society for Bone and Mineral Research (ASBMR), 23nd Annual Meeting, Phoenix Arizona, Oct. 12-16, 2001.
N.E. Lane, MD, J. Kumer, M. Khan, MD, R. Klein, MD, R.E. Stevens, Ph.D. and K.V. Phelps, B.S. Cenestin® (Synthetic Conjugated Estrogens, A) Maintains Trabecular Bone Mass, Structure And Bone Strength; Suppresses Bone Turnover; And Maintains Estrogenic Uterine Effects In Ovariectomized Rats. American Society for Bone and Mineral Research (ASBMR), 23nd Annual Meeting, Phoenix Arizona, Oct. 12-16, 2001.
R.E. Stevens, PhD, S.A. Ayres, PhD, J. Tai, MS2, K.V. Phelps, B.S. Effect of ERT on Vasomotor Symptoms: Impact of Cigarette Smoking. North American Menopausal Society (NAMS), New Orleans, LA, Oct. 4-6, 2001.
K.V. Phelps, BS, R.E. Stevens, PhD, J. Tai, MS, S.A. Ayres, PhD. Placebo Effect in Vasomotor Studies: Reflects Reduction in Frequency Not Severity. North American Menopausal Society (NAMS), New Orleans, LA, Oct. 4-6, 2001.
N.E. Lane, MD, J. Kumer, M. Khan M.D., R.E. Stevens, Ph.D. and K.V. Phelps, B.S. Cenestin® (Synthetic Conjugated Estrogens, A) Maintains Trabecular Bone Mass And Structure, Bone Strength And Suppresses Bone Turnover In Ovariectomized Rats. 4th International Symposium, Women’s Health and Menopause, Washington, D.C., May 19-23, 2001.
S.A. Ayres, Ph.D., R. E. Stevens, Ph.D. and K.V. Phelps, B.S. Relationship Between BMI And Biochemical Markers Of Bone Turnover In Early Postmenopausal Women Receiving Cenestin® (Synthetic Conjugated Estrogens, A). 4th International Symposium, Women’s Health and Menopause, Washington, D.C., May 19-23, 2001.
Ruth E. Stevens, Ph.D., Stacey A. Ayres, Ph.D., Ray Klein, M.D. and Ken V. Phelps, B.S. Effect Of ERT On Climacteric Symptoms In African-American And Caucasian Menopausal Women: Influence Of Body Mass Index. American College of Obstetricians and Gynecologists (ACOG) 50th Annual Meeting, Chicago, Illinois, April 28-May 2, 2001.
Ken V. Phelps, B.S., Ray Klein, M.D. and Ruth E. Stevens, Ph.D. Formulation Contributes To Drug Delivery Differences In Plasma Level Profiles Of Estrogens. American College of Obstetricians and Gynecologists (ACOG) 50th Annual Meeting, Chicago, Illinois, April 28-May 2, 2001.
RE Stevens, KV Phelps. Single and Multiple Dose Pharmacokinetic of 0.625 mg Synthetic Conjugated Estrogens, A (Cenestin®) Tablets After 90 Days of Administration. American Association of Pharmaceutical Scientists (AAPS) 16th Annual Meeting, Indianapolis, Indiana, Oct. 29 – Nov. 2, 2000.
RE Stevens, SA Ayres, KV Phelps. Biological Variability of Biochemical Markers of Bone Turnover in Clinical Study Following 90 Day Treatment of a New Synthetic Conjugated Estrogens, A (Cenestin®). American Society for Bone and Mineral Research (ASBMR), 22nd Annual Meeting, Toronto, Ontario, Canada, Sept. 22-26, 2000.
P Garnero, RE Stevens, SA Ayres, KV Phelps. Three-Month Placebo-Controlled Trial to Demonstrate the Effects of Synthetic Conjugated Estrogens, A (Cenestin®) on Biochemical Markers of Bone Turnover in Early Postmenopausal Women. ASBMR, 22nd Annual Meeting, Toronto, Ontario, Canada, Sept. 22-26, 2000.
SA Ayres, RE Stevens, KV Phelps. Evidence that Moderate Calcium and Vitamin D Dietary Supplementation Requires Estrogen to Prevent Bone Loss: Results of Biochemical Markers on Bone Turnover After 90-Day Treatment of a New Synthetic Conjugated Estrogens, A (Cenestin®). ASBMR, 22nd Annual Meeting, Toronto, Ontario, Canada, Sept. 22-26, 2000.
JA Simon, RE Stevens, SA Ayres, KV Phelps. Similar Response to ERT and Placebo Treatment in Perimenopausal Women: Significance for the Design of Vasomotor Symptom Trials. North American Menopausal Society (NAMS), Orlando, Florida, Sept. 7-11, 2000.
S.A. Ayres, Ph.D., R. E. Stevens, Ph.D. and K.V. Phelps, B.S. Relationship Between BMI And Biochemical Markers Of Bone Turnover In Early Postmenopausal Women Receiving Cenestin® (Synthetic Conjugated Estrogens, A). 4th International Symposium, Women’s Health and Menopause, Washington, D.C., May 19-23, 2001.
Ruth E. Stevens, Ph.D., Stacey A. Ayres, Ph.D., Ray Klein, M.D. and Ken V. Phelps, B.S. Effect Of ERT On Climacteric Symptoms In African-American And Caucasian Menopausal Women: Influence Of Body Mass Index. American College of Obstetricians and Gynecologists (ACOG) 50th Annual Meeting, Chicago, Illinois, April 28-May 2, 2001.
Ken V. Phelps, B.S., Ray Klein, M.D. and Ruth E. Stevens, Ph.D. Formulation Contributes To Drug Delivery Differences In Plasma Level Profiles Of Estrogens. American College of Obstetricians and Gynecologists (ACOG) 50th Annual Meeting, Chicago, Illinois, April 28-May 2, 2001.
RE Stevens, KV Phelps. Single and Multiple Dose Pharmacokinetic of 0.625 mg Synthetic Conjugated Estrogens, A (Cenestin®) Tablets After 90 Days of Administration. American Association of Pharmaceutical Scientists (AAPS) 16th Annual Meeting, Indianapolis, Indiana, Oct. 29 – Nov. 2, 2000.
RE Stevens, SA Ayres, KV Phelps. Biological Variability of Biochemical Markers of Bone Turnover in Clinical Study Following 90 Day Treatment of a New Synthetic Conjugated Estrogens, A (Cenestin®). American Society for Bone and Mineral Research (ASBMR), 22nd Annual Meeting, Toronto, Ontario, Canada, Sept. 22-26, 2000.
P Garnero, RE Stevens, SA Ayres, KV Phelps. Three-Month Placebo-Controlled Trial to Demonstrate the Effects of Synthetic Conjugated Estrogens, A (Cenestin®) on Biochemical Markers of Bone Turnover in Early Postmenopausal Women. ASBMR, 22nd Annual Meeting, Toronto, Ontario, Canada, Sept. 22-26, 2000.
SA Ayres, RE Stevens, KV Phelps. Evidence that Moderate Calcium and Vitamin D Dietary Supplementation Requires Estrogen to Prevent Bone Loss: Results of Biochemical Markers on Bone Turnover After 90-Day Treatment of a New Synthetic Conjugated Estrogens, A (Cenestin®). ASBMR, 22nd Annual Meeting, Toronto, Ontario, Canada, Sept. 22-26, 2000.
JA Simon, RE Stevens, SA Ayres, KV Phelps. Similar Response to ERT and Placebo Treatment in Perimenopausal Women: Significance for the Design of Vasomotor Symptom Trials. North American Menopausal Society (NAMS), Orlando, Florida, Sept. 7-11, 2000.
RE Stevens, SA Ayres, KV Phelps. Effect of ERT on Vasomotor Symptoms: Unique Clinical Trial Indicates Results Independent of Race or Body Mass. NAMS, Orlando, Florida, Sept. 7-11, 2000.
RE Stevens, SA Ayres, KV Phelps. Biochemical Markers of Bone Turnover: Clinical Study Design Intersubject Variability Considerations During 90 Day Treatment of a New Synthetic Conjugated Estrogens (Cenestin®). World Congress on Osteoporosis 2000, Chicago, Illinois, June 15-18, 2000.
P Garnero, RE Stevens, SA Ayres, KV Phelps. Short-term Effects of a New Synthetic Conjugated Estrogens (Cenestin®) on Biochemical Markers of Bone Turnover in Early Postmenopausal Women. World Congress on Osteoporosis 2000, Chicago, Illinois, June 15-18, 2000.
RE Stevens, H Gabelnick, G Duncan, KA Kook. A Relative Bioavailability Study of a New Formulation of Levonorgestrel 0.75 mg Tablets in Healthy Female Adults. American Association of Pharmaceutical Scientists (AAPS) 15th Annual Meeting, New Orleans, November 14-18, 1999.
D Heller, RS Stevens, D Davidson, J Donovan, S Burke. Absorption of 14C-Colesevelam Hydrochloride in Healthy Male and Female Adult Volunteers. AAPS 15th Annual Meeting, New Orleans, November 14-18, 1999.
KV Phelps, L Tothfalusi, L Endrenyi, RE Stevens. A Comparison of Average and Individual Bioequivalence of Two Oral Formulations of Conjugated Estrogens 0.625 mg Tablets. AAPS 15th Annual Meeting, New Orleans, November 14-18, 1999.
RE Stevens, J Konsil, SL Silletti, DH Upmallis, FL Cone. Bioavailability Study of a 1200 mg Miconazole Nitrate Vaginal Ovule in Healthy Female Adults. AAPS 13th Annual Meeting, San Francisco, California, November 15-19, 1998.
RE Stevens, J Konsil, SL Silletti. A Unique Perspective to Optimize Study Design Using Simulation to Estimate Drug Absorption of a New 1 Day 1200 mg Miconazole Nitrate Vaginal Ovule in Normal Volunteers. AAPS 13th Annual Meeting, San Francisco, California, November 15-19, 1998.
RE Stevens, KH Hanford, KV Phelps, S Wason, JC Kisicki, IE Weston, SL Cusack. A Unique 12 Week Clinical Trial Determining the Efficacy of Synthetic Conjugated Estrogens in the Treatment of Vasomotor Symptoms in Menopausal Women. AAPS 13th Annual Meeting, San Francisco, California, November 15-19, 1998.
J Konsil, RE Stevens, T Limsakun, DH Mason. Modeling of Carbamazepine and Carbamazepine-Epoxide after Multiple Dosing of CarbatrolÒ Extended-Release Beads and Tegretol-XR®. AAPS 13th Annual Meeting, San Francisco, California, November 15-19, 1998.
RE Stevens, J Konsil, SL Silletti, S Wason, L Gonzalez, LR Schwocho. A Dose-Ascending Study of CS-834 Pharmacokinetics After Single-Dose Oral Administration in Healthy Adults. American College of Clinical Pharmacy (ACCP), Nov 9-11, 1998.
RE Stevens, J Konsil, SL Silletti, S Wason, L Gonzalez, LR Schwocho. A Multiple Dose-Ascending Study of a New Orally Active Antibiotic Prodrug CS-834 in Healthy Adults Volunteers. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 24-27, 1998.
RE Stevens, T Limsakun, G Evans, DH Mason. A Controlled, Randomized Evaluation of the Steady-State Pharmacokinetics of Carbatrol® Extended-Release Capsules and Tegretol-XRÒ. American Academy of Neurology (AAN), Minneapolis, Minnesota, April 26-May 1, 1998.
RE Stevens, EG Pearson, JW Ayres. Determination of Theophylline and Dyphylline Concentrations in CSF and Plasma When Administered Concomitantly and Alone in Horses. AAPS Regional Meeting, Reno, Nevada, February 25-28, 1990
S.A. Ayres, Ph.D. Cardioprotective effect of 17b-estradiol on lipid peroxidation. Midwest American College of Sports Medicine Conference 1998, June, Cleveland, OH.
Ayres SA, Abplanalp W, Liu JH and Subbiah MTR. Mechanisms involved in the protective effect of estradiol-17b on lipoprotein peroxidation and DNA damage. Society of Gynecological Investigation, 1998, March 13-18, Atlanta, GA.
Abplanalp W, Ayres SA, Scheiber MD, Moon K, Kessel B, Liu JH and Subbiah MTR. Potential role of HDL in mediating the antioxidant effect of estrogens on LDL peroxidation. Society of Gynecological Investigation, 1998, March 13-18, Atlanta, GA.
Ayres SA, Tang M and Subbiah MTR. Estradiol-17bas an antioxidant: Some distinct features when compared to common fat-soluble antioxidants. Experimental Biology 1996, April, Washington, DC.
Ayres SA, Baer J and Subbiah MTR. Exercise induced increase in lipid peroxidation parameters in amenorrheic female athletes. Society of Gynecological Investigation, 1996, March 19-22, San Diego, CA.
Tang M, Abplanalp W, Ayres SA and Subbiah MTR. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Experimental Biology 1995, April 9-13, Atlanta, GA.
RE Stevens, A Carlin, TM Ludden. Mefloquine and Valproic Acid Pharmacokinetics Following Coadministration To Rats. AAPS 9th Annual Meeting, San Diego, California, November 7-10, 1994.
RE Stevens, GK Shiu, CT Viswanathan, JW Ayres. Pharmacodynamics of Ibuprofen Input Rate on Antipyresis in Rats With Induced Fever. AAPS 7th Annual Meeting, San Antonio, Texas, November 15-19, 1992.